The markets have been awfully tricky to traverse in 2016, but jittery investment sentiment did nothing to stanch deal flows during the year. Aside from the "gorilla deal" of SABMiller being acquired by Anheuser-Busch InBev, there were a good number of other smaller, but significant, transactions that would have kept corporate advisory fees ticking over nicely. These included Mediclinic International’s reverse takeover of Al Noor Hospital Group, a property deal between gaming and hotel group Tsogo Sun and Hospitality, the Blue Label Telecoms tilt at a major stake in Cell C, HCI’s sale of KWV’s operating assets to Vasari, empowerment group Brimstone’s topping up of its shareholding in Sea Harvest (which in turn took on strong Australian flavours), enX’s buyout of Eqstra, health-care conglomerate Ascendis’s clinching of two sizeable offshore acquisitions, Stellar Capital Partners’ purchase of Prescient and the securing by Amecor and Country Bird Holdings of a negative control block in ...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.